Search for AstraZeneca PLC and
  1. 20 hours ago

    AstraZeneca and Eli Lilly to unite for Alzheimer’s drug challenge

    AstraZeneca has struck a deal to jointly develop a treatment for Alzheimer’s disease with Eli Lilly of the US in a...

  2. 22 hours ago

    AstraZeneca swallows bittersweet pill with Eli Lilly Alzheimer’s deal

    Consciousness, the lens through which humans perceive the world, is ill-adapted for perceiving itself. The paradox is...

Special Reports

  1. 50 Top Business Ideas

    The FT puts the spotlight on which inventions and innovations have helped to create to...
  2. Engineering the Future

    Many of the world’s most exciting companies have engineering innovation at their heart...
Search more Special Reports on this topic.

  1. September 15, 2014

    Takeover Panel proposes tougher rules for deal promises

    The body that polices UK dealmaking has proposed strengthening its governing Takeover Code to address promises made during...

  2. September 11, 2014

    Pfizer says ‘window still open’ for tax inversions

    Pfizer says the window is still open for US companies to use transatlantic deals to lower their tax rates despite President...

  3. August 31, 2014

    Imperial College London’s new head welcomes political promotion of science

    In the heated debate that followed Pfizer’s attempted takeover of AstraZeneca earlier this year, the government’s attempts...

  4. August 29, 2014

    AstraZeneca gains on renewed bid chatter

    AstraZeneca was among the FTSE 100 leaders on Friday as bid chatter continued to prod the drug company’s shares higher. The...

  5. August 25, 2014

    Chi-Med draws on the past for the future

    Hutchison China MediTech represents the past and the future of China’s pharmaceuticals industry. Much of its revenues come...

  6. August 24, 2014

    Pfizer weighs options on AstraZeneca bid

    Pfizer is considering its acquisition options as a potential path opens this week for the US drugmaker to renew its pursuit...

  7. August 21, 2014

    Drugmaker link-up puts Astra on top

    The UK’s two biggest drugmakers both made it on to the FTSE 100 leaderboard after AstraZeneca developed a partnership that...

  8. August 21, 2014

    Drugmakers help lift FTSE 100

    The FTSE 100’s two biggest drugmakers were on the leaderboard on Thursday after AstraZeneca developed a partnership it hoped...

  9. August 20, 2014

    What next for M&A now the bubble has burst?

    Tuesday August 5 was a bad day for all those hoping the mergers and acquisitions boom had further to run. Investment bankers...

  10. August 19, 2014

    DoJ closes AstraZeneca probe without bringing charges

    US authorities have closed a 10-month investigation into contentious drug trial data surrounding an important AstraZeneca...

  11. August 19, 2014

    AstraZeneca tops FTSE 100

    AstraZeneca made the best single gain on the FTSE 100 on Tuesday after the drug company welcomed news that the US...

  12. August 7, 2014

    Viking raiders will bring Norse sense to company votes

    “From the wrath of the Northmen, oh lord, deliver us,” were the words gabbled by Dark Age peasants in hopes of warding off...

  13. August 6, 2014

    Pharma shares slide on fears of ‘tax inversion’ clampdown

    Investors fled global healthcare stocks on Wednesday after the Obama administration threatened action to halt the wave of...

  14. August 6, 2014

    FTSE 100 bid stocks lead broad losses

    Stocks at the centre of recent bid activity faltered on the FTSE 100 on Wednesday, as jitters spread from news overnight of...

  15. August 5, 2014

    Corporate acquirors take early aim at their target’s investors

    To win investor support for last month’s $53bn takeover of rival drugmaker Shire, AbbVie delivered a blunt message to its...

  16. August 4, 2014

    High cost to AstraZeneca independence

    The cost of AstraZeneca remaining independent may be greater than investors think, according to Barclays analysts. The...

  17. August 4, 2014

    Bristol-Myers Squibb in venture to turn US research into drugs

    Allied Minds, a Boston-based science and technology development company, has joined forces with biopharmaceutical giant...

  18. August 4, 2014

    AstraZeneca chairman Leif Johansson defends Pfizer rebuff

    Leif Johansson wants to set something straight: he does not want to be prime minister of Sweden. This was just one of the...

  19. August 3, 2014

    Europe delivers earnings growth for the first time in three years

    For the first time in three years, Europe’s companies are delivering earnings growth. But the good news risks being...

  20. July 31, 2014

    AstraZeneca raises full-year earnings guidance

    AstraZeneca raised its full-year earnings guidance on Thursday as Pascal Soriot, chief executive, declared “significant...

  21. July 30, 2014

    AstraZeneca to bolster respiratory drugs with Almirall deal

    AstraZeneca has bought a range of respiratory drugs from Almirall of Spain for up to $2.1bn in its biggest deal since...

  22. July 22, 2014

    US warned of up to 25 groups eyeing foreign switch to cut tax

    Up to 25 more US companies are considering relocating overseas to cut their tax bills this year, a Democratic senator has...

  23. July 18, 2014

    AstraZeneca unveils plans for £330m R&D centre in Cambridge

    AstraZeneca’s commitment to UK science was at the heart of its defence against Pfizer’s £69bn takeover bid in May. Two...

  24. July 16, 2014

    Eli Lilly joins forces with UK biotech to develop cancer drugs

    Eli Lilly has entered the race to develop a new generation of oncology drugs, which harness the immune system to kill cancer...

  25. July 16, 2014

    David Cameron moves to boost UK life sciences

    The appointment of George Freeman in a newly created life sciences role in Tuesday’s reshuffle marks the prime minister’s...

  26. July 14, 2014

    AbbVie/Shire - join us at 12 for a live discussion

    The above is a clause from the Medtronic/Covidien merger agreement of course – although it allows Medtronic to walk away...

  27. July 13, 2014

    Vince Cable plans to toughen up takeover rules

    Vince Cable plans to strengthen Britain’s takeover rules to make it harder for international bidders to renege on promises...

  28. July 8, 2014

    Cable backtracks on move to protect science industry

    Vince Cable has signalled the coalition will resist the Labour party’s demands for stronger government powers to intervene...

  29. July 8, 2014

    AbbVie avoids Pfizer errors in bear hug against Shire

    My pals are bigger than your pals. AbbVie has resorted to an old playground intimidation tactic, by implying a majority of...

  30. July 7, 2014

    Woodford goes big on AstraZeneca in new fund

    Neil Woodford, one of Britain’s most celebrated fund managers, has revealed that drugmaker AstraZeneca is the largest...

  31. July 2, 2014

    Drug groups welcome UK push to tackle superbugs

    Drugmakers have welcomed the appointment of Jim O’Neill, the former Goldman Sachs chief economist, to lead a UK...

  32. July 1, 2014

    AstraZeneca chief increases stake in drugmaker

    AstraZeneca’s chief executive has signalled his confidence in the company’s prospects by buying £2m worth of its shares,...

  33. June 29, 2014

    Global dealmaking shows return to vigour

    It was with qualified optimism that Ian Read, Pfizer’s chief executive, boarded his private jet to London on the penultimate...

  34. Business Blog

    June 27, 2014

    Defensive play in the World Cup of corporate taxation

    The global system for taxing multinational companies is broken, but no country wants to alter it too radically for fear of...

  35. June 26, 2014

    Not all AGM protests are centred on executive pay

    Exactly a year ago, Li Ruigang was one of the most unpopular directors at any FTSE 100 company – at least as far as...

  36. June 20, 2014

    AstraZeneca set to bolster takeover defences

    AstraZeneca is considering selling the rights to some of its future revenues in a move that would boost the UK drugmaker’s...

  37. June 18, 2014

    David Cameron launches world’s biggest dementia study

    The world’s biggest study of dementia will be unveiled by David Cameron on Thursday as part of a push worth more than £100m...

  38. June 17, 2014

    Major pharmaceutical groups may be too big to succeed

    As Pfizer eyed a £70bn takeover of AstraZeneca this spring, the prospective deal highlighted an awkward truth for the chief...

Search for AstraZeneca PLC and

RELATED VIDEOS

Videos from FT.com that closely match this topic

  1. Lex on the rejection of Pfizer's ‘final’ bid...
    May 19, 2014

    Lex on the rejection of Pfizer's ‘final’ bid

  2. The FT debates Pfizer's takeover bid for AstraZeneca...
    May 13, 2014

    The FT debates Pfizer's takeover bid for AstraZeneca

  3. CEO Pascal Soriot on AstraZeneca's move to Cambridge...
    July 3, 2013

    CEO Pascal Soriot on AstraZeneca's move to Cambridge